The impact of advanced patient age on mortality after allogeneic hematopoietic stem cell Transplantation (alloHSCT) for Non-Hodgkin's Lymphoma (NHL): A retrospective study by the EBMT Lymphoma Working Party

被引：0

作者：

Kyriakou, C. ^{[1
]}

Boumendil, A. ^{[2
]}

Finel, H. ^{[2
]}

Schmitz, N. ^{[3
]}

Mackinnon, S. ^{[1
]}

Lenhoff, S. ^{[4
]}

Fegueux, N. ^{[5
]}

Or, R. ^{[6
]}

Volin, L. ^{[7
]}

Sengeloev, H. ^{[8
]}

Blaise, D. ^{[9
]}

Chevallier, P. ^{[10
]}

Browne, P. ^{[11
]}

Craddock, C. ^{[12
]}

Niederwieser, D. ^{[13
]}

Pagliuca, A. ^{[14
]}

Bornhaeuser, M. ^{[15
]}

Dreger, P. ^{[16
]}

机构：

[1] Univ Coll London Hosp, Haematol, London, England

[2] EBMT, Lymphoma Working Party, Paris, France

[3] Asklepios Klin St Georg, Haematol, Hamburg, Germany

[4] Skanes Univ Hosp, Haematol, Lund, Sweden

[5] CHU Lapeyronie, Haematol, Montpellier, France

[6] Hadassah, Haematol, Jerusalem, Israel

[7] Univ Helsinki, Cent Hosp, Haematol, Helsinki, Finland

[8] Rigshosp, Haematol, DK-2100 Copenhagen, Denmark

[9] Inst J Paoli I Calmettes, Haematol, F-13009 Marseille, France

[10] CHU Nantes, Haematol, F-44035 Nantes 01, France

[11] St James Hosp, Haematol, Dublin 8, Ireland

[12] Queen Elizabeth Hosp, Haematol, Birmingham B15 2TH, W Midlands, England

[13] Univ Hosp, Haematol, Leipzig, Germany

[14] GKT Sch Med, Haematol, London, England

[15] Univ Klinikum, Haematol, Dresden, Germany

[16] Univ Heidelberg Hosp, Dept Internal Med, Heidelberg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2016年 / 51卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O119

引用

页码：S69 / S70

页数：2

共 50 条

[31] Late relapses following autologous hematopoietic stem cell (ASCT) transplantation for non-Hodgkin's lymphoma (NHL).
Bierman, PJ
Vose, JM
Lynch, JC
Bociek, RG
Morris, ME
Armitage, JO
BLOOD, 1999, 94 (10) : 610A - 610A
[32] Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHCT) for Patients Relapsing after Autologous Stem Cell Transplantation (autoHCT) for B Cell Non-Hodgkin Lymphoma (NHL)
Freytes, Cesar O.
Carreras, Jeanette
Zhang, Mei-Jie
Laport, Ginna G.
Van Besien, Koen
Lazarus, Hillard M.
Hari, Parameswaran
BLOOD, 2008, 112 (11) : 175 - 176
[33] Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT
Martinez, Carmen
Boumendil, Ariane
Romejko-Jarosinska, Joanna
Anagnostopoulos, Achilles
Faber, Edgar
Poire, Xavier
Yakoub-Agha, Ibrahim
Akhtar, Saad
Gurman, Gunhan
Pavone, Vincenzo
Halaburda, Kazimierz
Sousa, Aida Botelho
Ghesquieres, Herve
Finel, Herve
Khvedelidze, Irma
Montoto, Silvia
Sureda, Anna
LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2915 - 2922
[34] The outcome of BEAC conditioning regimen prior to autologous stem cell transplant in non-Hodgkin lymphoma (NHL) and comparison with BEAM conditioning: a Lymphoma Working Party-EBMT study
Robinson, S.
Boumendil, A.
Finel, H.
Sureda, A.
Hermine, O.
Dreger, P.
Montoto, S.
BONE MARROW TRANSPLANTATION, 2017, 52 : S71 - S72
[35] Autologous Hematopoietic Stem Cell Transplantation in Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party
Berning, Philipp
Ngoya, Maud
Finel, Herve
Thani, Nassila
Shumilov, Evgenii
Wu, Depei
Huang, Haiwen
Kim, Won Seog
Cairoli, Anne
Tucci, Alessandra
Dachy, Guillaume
Gounot, Romain
Wilke, Anne
Werth, Marek
Scheid, Christof
Dreger, Peter
Lorenzo, Jose Luis Lopez
Bloor, Adrian
Romejko-Jarosinska, Joanna
Gadisseur, Alain
Schroers, Roland
Remenyi, Peter Pal
Sirvent, Anne
Poiani, Monica
Halahleh, Khalid
Galimard, Jacques-Emmanuel
Lenz, Georg
Glass, Bertram
Balari, Ana Maria Sureda
Bazarbachi, Ali
Schmitz, Norbert
BLOOD, 2024, 144 : 3070 - 3072
[36] Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT
Sureda, Anna
Stavrik, Sonja Genadieva
Boumendil, Ariane
Finel, Herve
Khvedelidze, Irma
Dietricht, Sascha
Dreger, Peter
Hermine, Olivier
Kyriakou, Chara
Robinson, Stephen
Schmitz, Norbert
Schouten, Harry C.
Tanase, Alina
Montoto, Silvia
BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2170 - 2179
[37] Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT
Anna Sureda
Sonja Genadieva Stavrik
Ariane Boumendil
Hervé Finel
Irma Khvedelidze
Sascha Dietricht
Peter Dreger
Olivier Hermine
Chara Kyriakou
Stephen Robinson
Norbert Schmitz
Harry C. Schouten
Alina Tanase
Silvia Montoto
Bone Marrow Transplantation, 2020, 55 : 2170 - 2179
[38] Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Wrench, David
Gribben, John G.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 1051 - +
[39] Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT
Bento, Leyre
Boumendil, Ariane
Finel, Herve
Khvedelidze, Irma
Blaise, Didier
Fegueux, Nathalie
Castagna, Luca
Forcade, Edouard
Chevallier, Patrice
Mordini, Nicola
Brice, Pauline
Deconinck, Eric
Gramatzki, Martin
Corradini, Paolo
Hunault, Mathilde
Musso, Maurizio
Tsoulkani, Anna
Caballero, Dolores
Nati, Sandro
Montoto, Silvia
Sureda, Anna
BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 655 - 663
[40] Feasibility of allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity (RI) conditioning regimen for non-Hodgkin's lymphoma (NHL).
Kusumi, E
Tanimoto, TE
Kami, M
Hamaki, T
Yuji, K
Ueyama, J
Miyakoshi, S
Morinaga, S
Kanda, Y
Makimoto, A
Kataoka, I
Kim, SW
Ohnishi, M
Nakai, K
Tobinai, K
Tanosaki, R
Mineishi, S
Takaue, Y
Mutou, Y
BLOOD, 2001, 98 (11) : 377B - 377B

← 1 2 3 4 5 →